Skip to main content
. Author manuscript; available in PMC: 2013 Dec 7.
Published in final edited form as: Cancer J. 2011 Jul-Aug;17(4):10.1097/PPO.0b013e31822c28b3. doi: 10.1097/PPO.0b013e31822c28b3

Table 1.

Adverse Events (AEs) Listed in U.S. Drug Labels

Indication # of U.S. Drug Labels Average # of AEs per Label Proportion of AEs That Are Symptoms
Asthma 35 54 54%
Breast cancer 32 83 38%
Gastroesophageal reflux disease 18 121 47%
Hyperlipidemia 28 86 46%
Osteoarthritis 39 94 43%